The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

A group of public health professionals, scientists and others that sued the U.S. Food and Drug ​Administration to obtain ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

COVID-19 vaccine maker BioNTech (BNTX) has conducted confidential discussions with prospective bidders regarding plans to shutter manufacturing locations in Germany, German business daily Handelsblatt ...

The US government has agreed to pay Pfizer and BioNTech $1.95 billion for 100 million doses of their COVID-19 vaccine if it ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

When Pfizer Inc. and BioNTech SE’s Covid-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of ...

Billions of doses later, a global review has found that mRNA vaccines are safe and highly effective. Not only have they ...

“Acting within the time allowed by law cannot be inequitable merely because a court later dislikes the duration of the process. Hyatt gives the Supreme Court a clean opportunity to enforce that line.” ...

The study was originally meant to be published in a CDC weekly report in March.